Literature DB >> 33778762

Multiparameter MRI and Clinical Factors for Predicting Early Response to Chemoradiotherapy in Cervical Cancer.

Sanaz Javadi, Vikas Kundra.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33778762      PMCID： PMC7983722          DOI： 10.1148/rycan.2021209038

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  4 in total

1.  External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Martin Vallières; Marie-Charlotte Desseroit; Omar Miranda; Philippe Robin; Pietro Andrea Bonaffini; Joanne Alfieri; Ingrid Masson; Augustin Mervoyer; Caroline Reinhold; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-07       Impact factor: 9.236

2.  Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Marie-Charlotte Desseroit; Omar Miranda; Jean-Pierre Malhaire; Philippe Robin; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-09       Impact factor: 9.236

3.  Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.

Authors:  Xiaomin Zheng; Weiqian Guo; Jiangning Dong; Liting Qian
Journal:  Magn Reson Imaging       Date:  2020-07-02       Impact factor: 2.546

4.  Radiomic features of cervical cancer on T2-and diffusion-weighted MRI: Prognostic value in low-volume tumors suitable for trachelectomy.

Authors:  Benjamin W Wormald; Simon J Doran; Thomas Ej Ind; James D'Arcy; James Petts; Nandita M deSouza
Journal:  Gynecol Oncol       Date:  2019-11-02       Impact factor: 5.482
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.